# First-in-Human (FIH) Study on the Feasibility and Safety of the TaviPilot Augmented Reality Guidance Software

> **NCT07043075** · NA · NOT_YET_RECRUITING · sponsor: **Caranx Medical** · enrollment: 10 (estimated)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** TAVR using a guidance software

## Key facts

- **NCT ID:** NCT07043075
- **Lead sponsor:** Caranx Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2025-11-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07043075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07043075, "First-in-Human (FIH) Study on the Feasibility and Safety of the TaviPilot Augmented Reality Guidance Software". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07043075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*